Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of add-on Eptinezumab Treatment to Brief Educational Intervention for the Preventive Treatment of Migraine in Patients With Dual Diagnosis of Migraine and Medication Overuse Headache
Latest Information Update: 26 Jun 2025
At a glance
- Drugs Eptinezumab (Primary)
- Indications Headache; Migraine
- Focus Therapeutic Use
- Acronyms RESOLUTION
- Sponsors Lundbeck A/S
Most Recent Events
- 21 Jun 2025 According to Lundbeck A/S Media Release, data from this trial presented at the 11th Congress of the European Academy of Neurolog
- 21 Jun 2025 Primary endpoint (Change From Baseline in the Number of Monthly Migraine Days (MMDs)) has been met as per results published in the Lundbeck A/S Media Release
- 21 Jun 2025 Results published in the Lundbeck A/S Media Release